Ajanta Pharma Q1 results: Consolidated PAT up 19% to ₹208 crore, declares dividend

[Bilgin]

Ajanta Pharma Q1 results: Consolidated PAT up 19% to ₹208 crore, declares dividend Ajanta Pharma reports Q1 revenue of Rs. 1,021 crore, EBITDA of Rs. 271 crore, and PAT of Rs. 208 crore, with a 19% increase in revenue and PAT. The company declares a 1st interim dividend of Rs. 315 crore for FY 2024, including a special dividend of Rs. 15 per share to mark its 50th anniversary